ARIBIO Holdings Inc.: debt-to-equity, ROE and more
KOSDAQ, Legal name ARIBIO Holdings Inc.
Latest figures are the FY2025 separate summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 55.8%
- Equity ratio
- 64.2%
- ROE
- -8.5%
- Op. margin
- -17.6%
- Rev. growth
- -24.5%
- Interest coverage
- n/a
Condition flags
- Latest operating profit is not above zero, or not reported.
- Operating loss for 2 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
No dividend data yet for this company.
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 separate | 54.1% | 64.9% | 8.7% | 7.2% | n/a |
| FY2022 separate | 57.8% | 63.4% | -10.0% | -7.7% | -20.2% |
| FY2023 separate | 156.6% | 39.0% | -10.7% | 0.9% | 7.0% |
| FY2024 separate | 49.7% | 66.8% | -52.3% | -13.1% | -15.3% |
| FY2025 separate | 55.8% | 64.2% | -8.5% | -17.6% | -24.5% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩70.0B | ₩55.9B | ₩59.8B | ₩50.7B | ₩38.3B |
| Operating profit | ₩5.1B | -₩4.3B | ₩515.6M | -₩6.6B | -₩6.7B |
| Pre-tax income | ₩5.2B | -₩5.2B | -₩7.6B | -₩42.1B | -₩7.1B |
| Net income | ₩4.2B | -₩4.3B | -₩6.7B | -₩41.0B | -₩7.7B |
| Total assets | ₩73.9B | ₩68.4B | ₩160.2B | ₩117.3B | ₩141.6B |
| Total liabilities | ₩25.9B | ₩25.1B | ₩97.7B | ₩39.0B | ₩50.7B |
| Total equity | ₩47.9B | ₩43.3B | ₩62.4B | ₩78.3B | ₩90.9B |
| Paid-in capital | ₩825.7M | ₩825.7M | ₩14.6B | ₩23.9B | ₩24.4B |
| Debt/equity (source value) | 54.1% | 57.8% | 156.6% | 49.7% | 55.8% |
Company outline (FSC)
- Market
- KOSDAQ
- Fiscal year end
- Dec
- Founded
- 1996-07-02
- Listed
- 20/11/06
- Employees
- 109
- Auditor
- 한울회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1211110051797
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 아리바이오홀딩스Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.